Cargando…
An open-label, dose-finding study of the combination of satraplatin and gemcitabine in patients with advanced solid tumors
Purpose: Satraplatin is a third generation oral platinum, which has demonstrated antitumor activity. The aim of this phase I study was to determine the maximum tolerated dose (MTD) of the combination of satraplatin and gemcitabine in patients previously treated with chemotherapy and in patients with...
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504330/ https://www.ncbi.nlm.nih.gov/pubmed/23189269 http://dx.doi.org/10.3389/fonc.2012.00175 |